CAS 1807758-81-1

N1-(5-(4-Chlorophenyl)oxazol-2-yl)benzene-1,3-diamine

CAS : 1807758-81-1

Formule : C₁₅H₁₂ClN₃O

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 285.7283

Ref: IN-DA01V51B

SIRT7 inhibitor 97491

CAS : 1807758-81-1

SIRT7 inhibitor 97491

Degré de pureté : ≥98%

Masse moléculaire : 285.73g/mol

Ref: 54-BUP02940

SIRT7 inhibitor 97491

CAS : 1807758-81-1

SIRT7 inhibitor 97491 is an HDAC inhibitor with high specificity for SIRT7 (IC50 = 325 nM). SIRT7 inhibitor 97491 promotes apoptosis through caspase pathway.

Formule : C₁₅H₁₂ClN₃O

Degré de pureté : 99.79%

Couleur et forme : Solid

Masse moléculaire : 285.73

Ref: TM-T39233

Sirt7 inhibitor 97491

CAS : 1807758-81-1

Sirt7 inhibitor 97491 is an anticancer drug that works by inhibiting the activity of Sirt7, a protein that promotes tumor growth. This inhibitor has been shown to be effective in human cancer cell lines and may have potential for use in cancer therapy. The drug has been tested in Chinese hamster ovary cells and was found to induce apoptosis, or programmed cell death, in these cells. Sirt7 inhibitor 97491 is an analog of chloroquine and can also inhibit kinases, which are enzymes involved in signaling pathways that regulate cell growth and division. In addition, this inhibitor has been found to increase the effectiveness of other anticancer drugs such as artesunate. Overall, Sirt7 inhibitor 97491 is a promising new drug candidate for the treatment of cancer.

Formule : C₁₅H₁₂ClN₃O

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 285.73 g/mol

Ref: 3D-HXC75881